J Jefferson P Perry

8PUBLICATIONS
78CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)HaematologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 26, 2026
Inhibition of ADSS2-mediated de novo AMP biosynthesis re-sensitizes acute myeloid leukemia to BH3 mimetics.

|Jun 05, 2026
Targeting the METTL1/m7G axis as a therapeutic strategy in myeloid leukemia.

|Apr 27, 2026
Targeting Cancer-Associated PCNA with AOH1996 Induces Mitotic Catastrophe and Enhances Cisplatin Therapy in Cervical Cancer.

|Apr 14, 2026
Allosteric inhibition of RAN decreases miR-126 biogenesis in endothelial cells and controls acute myeloid leukemia growth.

Melissa Valerio, Wenyuan Wei, Hyunjun Kang

|Dec 02, 2025
Osimertinib induces reversible cardiac dysfunction through the GATA4-MYLK3-MYL2 axis.

Kai Zhang, Alyssa Ayala, Ignacio Norambuena-Soto

|Dec 01, 2025
Targeting SUMOylation with Anacardic Acid Derivatives: Novel Insights into EGF Pathway Dysregulation in Cancer Using an In Silico Approach.

Sandhya Padmakumar, Boinapalli Gopichand, Anu R Melge

Pageof 2

Frequent Collaborators

2 joint publications

Le Xuan Truong Nguyen

2 joint publications

Jianjun Chen

2 joint publications

Guido Marcucci

2 joint publications

Bin Zhang